Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Differential anticancer drug delivery with a nanogel sensitive to bacteria-accumulated tumor artificial environment.

Xiong MH, Bao Y, Du XJ, Tan ZB, Jiang Q, Wang HX, Zhu YH, Wang J.

ACS Nano. 2013 Dec 23;7(12):10636-45. doi: 10.1021/nn403146t. Epub 2013 Nov 18.

PMID:
24200225
2.

Lipase-sensitive polymeric triple-layered nanogel for "on-demand" drug delivery.

Xiong MH, Bao Y, Yang XZ, Wang YC, Sun B, Wang J.

J Am Chem Soc. 2012 Mar 7;134(9):4355-62. doi: 10.1021/ja211279u. Epub 2012 Feb 23.

PMID:
22304702
3.

Evaluation of thermo-triggered drug release in intramuscular-transplanted tumors using thermosensitive polymer-modified liposomes and MRI.

Kokuryo D, Nakashima S, Ozaki F, Yuba E, Chuang KH, Aoshima S, Ishizaka Y, Saga T, Kono K, Aoki I.

Nanomedicine. 2015 Jan;11(1):229-38. doi: 10.1016/j.nano.2014.09.001. Epub 2014 Sep 16.

PMID:
25229542
4.

Low density lipoprotein as a targeted carrier for doxorubicin in nude mice bearing human hepatoma HepG2 cells.

Chu AC, Tsang SY, Lo EH, Fung KP.

Life Sci. 2001 Dec 21;70(5):591-601.

PMID:
11811903
5.

Fabrication and intracellular delivery of doxorubicin/carbonate apatite nanocomposites: effect on growth retardation of established colon tumor.

Hossain S, Yamamoto H, Chowdhury EH, Wu X, Hirose H, Haque A, Doki Y, Mori M, Akaike T.

PLoS One. 2013 Apr 16;8(4):e60428. doi: 10.1371/journal.pone.0060428. Print 2013.

6.

Bio-distribution and anti-tumor efficacy of PEG/PLA nano particles loaded doxorubicin.

Yu JJ, Lee HA, Kim JH, Kong WH, Kim Y, Cui ZY, Park KG, Kim WS, Lee HG, Seo SW.

J Drug Target. 2007 May;15(4):279-84.

PMID:
17487696
7.

Poly(L-aspartic acid) nanogels for lysosome-selective antitumor drug delivery.

Oh NM, Oh KT, Youn YS, Lee DK, Cha KH, Lee DH, Lee ES.

Colloids Surf B Biointerfaces. 2013 Jan 1;101:298-306. doi: 10.1016/j.colsurfb.2012.07.013. Epub 2012 Jul 20.

PMID:
23010033
8.

Dermatan carriers for neovascular transport targeting, deep tumor penetration and improved therapy.

Ranney D, Antich P, Dadey E, Mason R, Kulkarni P, Singh O, Chen H, Constantanescu A, Parkey R.

J Control Release. 2005 Dec 5;109(1-3):222-35. Epub 2005 Nov 14.

PMID:
16290245
9.

Integration of nanoassembly functions for an effective delivery cascade for cancer drugs.

Sun Q, Sun X, Ma X, Zhou Z, Jin E, Zhang B, Shen Y, Van Kirk EA, Murdoch WJ, Lott JR, Lodge TP, Radosz M, Zhao Y.

Adv Mater. 2014 Dec 3;26(45):7615-21. doi: 10.1002/adma.201401554. Epub 2014 Oct 18.

PMID:
25328159
10.

Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.

Lv S, Li M, Tang Z, Song W, Sun H, Liu H, Chen X.

Acta Biomater. 2013 Dec;9(12):9330-42. doi: 10.1016/j.actbio.2013.08.015. Epub 2013 Aug 17.

PMID:
23958784
11.
12.

Targeted and intracellular triggered delivery of therapeutics to cancer cells and the tumor microenvironment: impact on the treatment of breast cancer.

Moura V, Lacerda M, Figueiredo P, Corvo ML, Cruz ME, Soares R, de Lima MC, Simões S, Moreira JN.

Breast Cancer Res Treat. 2012 May;133(1):61-73. doi: 10.1007/s10549-011-1688-7. Epub 2011 Jul 30.

PMID:
21805188
13.
14.

Synthesis of disulfide-cross-linked polypeptide nanogel conjugated with a near-infrared fluorescence probe for direct imaging of reduction-induced drug release.

Xing T, Mao C, Lai B, Yan L.

ACS Appl Mater Interfaces. 2012 Oct 24;4(10):5662-72. doi: 10.1021/am301600u. Epub 2012 Oct 8.

PMID:
22974285
15.

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model.

Arap W, Pasqualini R, Ruoslahti E.

Science. 1998 Jan 16;279(5349):377-80.

16.

Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.

Gao W, Xiang B, Meng TT, Liu F, Qi XR.

Biomaterials. 2013 May;34(16):4137-49. doi: 10.1016/j.biomaterials.2013.02.014. Epub 2013 Mar 1.

PMID:
23453200
17.

Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment.

Chow EK, Zhang XQ, Chen M, Lam R, Robinson E, Huang H, Schaffer D, Osawa E, Goga A, Ho D.

Sci Transl Med. 2011 Mar 9;3(73):73ra21. doi: 10.1126/scitranslmed.3001713.

18.

LyP-1 modification to enhance delivery of artemisinin or fluorescent probe loaded polymeric micelles to highly metastatic tumor and its lymphatics.

Wang Z, Yu Y, Ma J, Zhang H, Zhang H, Wang X, Wang J, Zhang X, Zhang Q.

Mol Pharm. 2012 Sep 4;9(9):2646-57. doi: 10.1021/mp3002107. Epub 2012 Aug 13.

PMID:
22853186
19.

Remote triggered release of doxorubicin in tumors by synergistic application of thermosensitive liposomes and gold nanorods.

Agarwal A, Mackey MA, El-Sayed MA, Bellamkonda RV.

ACS Nano. 2011 Jun 28;5(6):4919-26. doi: 10.1021/nn201010q. Epub 2011 Jun 2.

PMID:
21591812
20.

Tetraiodothyroacetic acid-tagged liposomes for enhanced delivery of anticancer drug to tumor tissue via integrin receptor.

Lee S, Kim J, Shim G, Kim S, Han SE, Kim K, Kwon IC, Choi Y, Kim YB, Kim CW, Oh YK.

J Control Release. 2012 Dec 10;164(2):213-20. doi: 10.1016/j.jconrel.2012.05.043. Epub 2012 Jun 2.

PMID:
22664473

Supplemental Content

Support Center